A biomarker is a gene molecule by which the biological state of the body is measured to predict the incidence of a particular disease. The biomarker-based technologies help in disease identification and in planning for an effective treatment. The market is valued at $45.47 billion in 2017 and is expected to reach $73.45 billion by 2024 growing with CAGR of 9.75%. The factors like increasing demand for cost-effective and non-invasive procedures, increasing adoption in multi-marker applications with good accuracy, increasing healthcare expenditure and R&D funding and increasing utility of biomarkers for diagnostic purposes are driving the market growth. The facts like the complex process and stringent government regulations and ethical problems and dilemma in the confirmation of results are restricting the market growth.

Research Study Objectives:

• Define, estimate, and forecast the Biomarker Technologies market statistics by technology, disease application, application and regions concerning the individual growth drivers, market trends and their contribution toward the Biomarker Technologies market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Biomarker Technologies Market Analysis
• Analysis and conclusions on the future Biomarker Technologies market outlook.

Top-down and bottom-up approaches are used to validate the Biomarker Technologies Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Biomarker Technologies Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Biomarker Technologies market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Biomarker Technologies market segmentation is as follows:

By Technology

• Omics Technology
  • Proteomics
  • Genomics
  • Transcriptomics
• Imaging technology
• Bioinformatics

By Application

• Drug discovery
• Diagnostics
• Personalized medicine

By Disease Application

• Cancer
• Diabetes
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Diseases
• Autoimmune Disorders
• Others

Geographical Analysis:

Biomarker Technologies Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customizations Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Biomarker Technologies Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Biomarker Technologies Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Biomarker Technologies market players, such as
  • Siemens Healthcare
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies Inc.
  • Affymetrix Inc.
• Along with these companies, many other companies are considered in the report while analysing the Global Biomarker Technologies competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.